secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tracon Pharmaceuticals, Inc. (—)
CIK:        0001394319
Form:       8-K
Filed at:   2024-04-08T23:59:59+00:00
Accession:  0000950170-24-042440
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRACON (TCON) implements 1-for-20 reverse stock split effective April 9, 2024
-----------------------------------------------------------------------------

- Board approved 1-for-20 reverse stock split; effective 5:00 p.m. ET on April 9, 2024.
- Post-split shares approx. 2.6 million; trading on split-adjusted basis from April 10, 2024.
- No fractional shares; holders entitled to fractional share will receive one full post-split share.
- Proportional adjustments to options, warrants, and equity plans; authorized shares unchanged at 60M.
- New CUSIP 89237H308; symbol TCON continues on Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024042440/0000950170-24-042440-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1394319/000095017024042440/tcon-20240408.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-042440

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer